146 related articles for article (PubMed ID: 34934721)
1. Pediatric Cutaneous Leishmaniasis: A Clinico-Epidemiological Study from North India.
Rather S; Yaseen A; Shah FY; Wani M; Krishan K; Zirak S; Sharma R; Hassan I; Dogra D; Rishi R
Indian Dermatol Online J; 2021; 12(6):852-859. PubMed ID: 34934721
[TBL] [Abstract][Full Text] [Related]
2. Clinical and epidemiological study of cutaneous leishmaniasis in two tertiary care hospitals of Jammu and Kashmir: An emerging disease in North India.
Rather S; Wani M; Shah FY; Bashir S; Yaseen A; Giri FA; Sharma R; Zeerak S; Jabeen Y; Hassan I; Dogra D; Rishi R
Int J Infect Dis; 2021 Feb; 103():138-145. PubMed ID: 33181331
[TBL] [Abstract][Full Text] [Related]
3. A new focus of cutaneous leishmaniasis in Jammu division of Jammu and Kashmir State, India.
Kaul N; Gupta V; Bhardwaj S; Dogra D; Dogra N
Indian J Dermatol Venereol Leprol; 2016; 82(2):145-50. PubMed ID: 26924403
[TBL] [Abstract][Full Text] [Related]
4. Clinical study of cutaneous leishmaniasis in the Kashmir Valley.
Wani GM; Ahmad SM; Khursheed B
Indian Dermatol Online J; 2015; 6(6):387-92. PubMed ID: 26753136
[TBL] [Abstract][Full Text] [Related]
5. Intralesional sodium stibogluconate alone or its combination with either intramuscular sodium stibogluconate or oral ketoconazole in the treatment of localized cutaneous leishmaniasis: a comparative study.
El-Sayed M; Anwar AE
J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):335-40. PubMed ID: 19744259
[TBL] [Abstract][Full Text] [Related]
6. A Clinico-Epidemiological Study of Cutaneous Leishmaniasis in a Non-Endemic Region of South Rajasthan.
Virath R; Gupta LK; Mehta S; Balai M; Mittal AK; Khare AK
Indian Dermatol Online J; 2021; 12(1):123-127. PubMed ID: 33768033
[TBL] [Abstract][Full Text] [Related]
7. Chronic Relapsing Cutaneous Leishmaniasis in an Elderly Female: A Rare Clinical Presentation from a Nonendemic Area.
Rather S; Bashir S; Bhat YJ; Hassan I
Indian Dermatol Online J; 2019; 10(2):165-167. PubMed ID: 30984593
[TBL] [Abstract][Full Text] [Related]
8. Lupoid cutaneous Leishmaniasis: A Report of Three Cases from Nonendemic Area.
Gupta LK; Meena S; Khare AK; Balai M; Mittal A; Mehta S
Indian J Dermatol; 2017; 62(5):548. PubMed ID: 28979030
[TBL] [Abstract][Full Text] [Related]
9. The Role of Histopathology and Immunohistochemistry in the Diagnosis of Cutaneous Leishmaniasis Without "Discernible" Leishman-Donovan Bodies.
Dias-Polak D; Geffen Y; Ben-Izhak O; Bergman R
Am J Dermatopathol; 2017 Dec; 39(12):890-895. PubMed ID: 29190217
[TBL] [Abstract][Full Text] [Related]
10. A new focus of cutaneous leishmaniasis in Himachal Pradesh (India).
Sharma RC; Mahajan VK; Sharma NL; Sharma A
Indian J Dermatol Venereol Leprol; 2003; 69(2):170-2. PubMed ID: 17642870
[TBL] [Abstract][Full Text] [Related]
11. Searching for cutaneous leishmaniasis in tribals from kerala, India.
S M S; T S A; R J; K V; Philip RR; Paul N
J Glob Infect Dis; 2010 May; 2(2):95-100. PubMed ID: 20606960
[TBL] [Abstract][Full Text] [Related]
12. Correlation of clinical, histopathological, and microbiological findings in 60 cases of cutaneous leishmaniasis.
ul Bari A; ber Rahman S
Indian J Dermatol Venereol Leprol; 2006; 72(1):28-32. PubMed ID: 16481706
[TBL] [Abstract][Full Text] [Related]
13. Treatment of cutaneous leishmaniasis with intralesional sodium stibogluconate.
Solomon M; Baum S; Barzilai A; Pavlotsky F; Trau H; Schwartz E
J Eur Acad Dermatol Venereol; 2009 Oct; 23(10):1189-92. PubMed ID: 19298486
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous Leishmaniasis in a Nonendemic Area of South Rajasthan: A Prospective Study.
Balai M; Gupta LK; Khare AK; Srivastava A; Mittal A; Singh A
Indian J Dermatol; 2016; 61(5):521-4. PubMed ID: 27688441
[TBL] [Abstract][Full Text] [Related]
15. Outbreak of cutaneous leishmaniasis in Fuenlabrada, Madrid.
Aguado M; Espinosa P; Romero-Maté A; Tardío JC; Córdoba S; Borbujo J
Actas Dermosifiliogr; 2013 May; 104(4):334-42. PubMed ID: 23567452
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous Leishmaniasis in a Saudi Arabian Soldier Stationed in the United States.
Laurent K; Susong J; Fillman E; Ritchie S
Mil Med; 2017 Jul; 182(7):e1953-e1956. PubMed ID: 28810997
[TBL] [Abstract][Full Text] [Related]
17. Synergistic Effect Of Oral Allopurinol And Intralesional Sodium Stibogluconate In The Treatment Of Cutaneous Leishmaniasis.
Rashid HU; Ullah I; Adeeb H; Zeb M; Mohammad A; Rehman N
J Ayub Med Coll Abbottabad; 2020; 32(4):558-561. PubMed ID: 33225663
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of short-duration (twice weekly) intralesional sodium stibogluconate in treatment of cutaneous Leishmaniasis in India.
Bumb RA; Mehta RD; Ghiya BC; Jakhar R; Prasad N; Soni P; Lezama-Davila C; Satoskar AR
Br J Dermatol; 2010 Oct; 163(4):854-8. PubMed ID: 20500797
[TBL] [Abstract][Full Text] [Related]
19. Molecular epidemiological survey of cutaneous leishmaniasis from Azad Jammu and Kashmir, Pakistan.
Shaheen N; Qureshi NA; Qureshi MZ; Fatima H; Afzal M; Alhewairini SS
Acta Trop; 2020 Jun; 206():105434. PubMed ID: 32126210
[TBL] [Abstract][Full Text] [Related]
20. Effect of Intralesional Sodium Stibogluconate Alone versus Combinations with Topical Trichloroacetic Acid 50% or Fractional Carbon Dioxide Laser on Cutaneous Leishmaniasis.
Ali SM; Ali MM; Kamel AM
Indian J Dermatol; 2023; 68(5):588. PubMed ID: 38099118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
